AstraZeneca PLC - Total Other Income Expense Net

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Income-Expense-Net" stands at -0.9959 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2024.

AstraZeneca PLC's third quarter result of -0.339 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -14.64 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of -0.339 Billion USD for the item "Total Other Income Expense Net" represents an increase of 65.63 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of -0.9959 Billion USD for the item "Total Other Income Expense Net" represents an increase of 39.39 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.27 Billion United States Dollars compared to the value the year prior.
The 1 year change is 1.27 Billion United States Dollars.
The 3 year change is 1.09 Billion United States Dollars.
The 5 year change is -0.0249 Billion United States Dollars.
The 10 year change is -0.0059 Billion United States Dollars.

The Serie's long term average value is -1.13 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.137 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +2.60 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2018, to it's latest available value, on 09/30/2025, is -1.03 Billion.